Comparison between EP Biocomposites IPO and Jay Jalaram Technologies IPO.
EP Biocomposites IPO is a SME Fixed Price IPO proposed to list at BSE SME while Jay Jalaram Technologies IPO is a SME Fixed Price proposed to list at NSE SME.
| EP Biocomposites IPO | Jay Jalaram Technologies IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Aryaman Financial Services Ltd. | Beeline Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Aryaman Capital Markets Ltd. | Sunflower Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of EP Biocomposites IPO is up to ₹6.00 Cr whereas the issue size of the Jay Jalaram Technologies IPO is up to ₹10.26 Cr. The final issue price of EP Biocomposites IPO is ₹126.00 per share and of Jay Jalaram Technologies IPO is ₹36.00 per share.
| EP Biocomposites IPO | Jay Jalaram Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹126.00 per share | ₹36.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | 3000 shares |
| Fresh Issue Size | 4,76,000 shares | 28,50,000 shares |
| Fresh Issue Size (Amount) | up to ₹6.00 Cr | up to ₹10.26 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 4,76,000 shares | 28,50,000 shares |
| Issue Size Total (Amount) | up to ₹6.00 Cr | up to ₹10.26 Cr |
EP Biocomposites IPO opens on Aug 29, 2022, while Jay Jalaram Technologies IPO opens on Aug 26, 2022. The closing date of EP Biocomposites IPO and Jay Jalaram Technologies IPO is Sep 05, 2022, and Aug 30, 2022, respectively.
| EP Biocomposites IPO | Jay Jalaram Technologies IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 29, 2022 | Aug 26, 2022 |
| Issue Close | Sep 05, 2022 | Aug 30, 2022 |
| Basis Of Allotment (Tentative) | Sep 08, 2022 | Sep 05, 2022 |
| Initiation of Refunds (Tentative) | Sep 09, 2022 | Sep 06, 2022 |
| Credit of Share (Tentative) | Sep 12, 2022 | Sep 07, 2022 |
| Listing date (Tentative) | Sep 13, 2022 | Sep 08, 2022 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
EP Biocomposites IPO P/E ratio is 26.2, as compared to Jay Jalaram Technologies IPO P/E ratio of 46.
| EP Biocomposites IPO | Jay Jalaram Technologies IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 98.97 | 100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 69.40 | 73.04 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 26.2 | 46 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹21.19 Cr. | ₹40.07 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 15.72 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 11.84 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.97 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹9.48 | ₹7.36 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 40.5 | 8.16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the EP Biocomposites IPO Retail Individual Investors (RII) are offered 2,38,000 shares while in Jay Jalaram Technologies IPO retail investors are offered 2,38,000 shares. Qualified Institutional Buyers (QIB) are offered in EP Biocomposites IPO and in Jay Jalaram Technologies IPO.
| EP Biocomposites IPO | Jay Jalaram Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 28,000 shares | 1,50,000 shares |
| QIB | ||
| NII | 2,38,000 shares | 14,25,000 shares |
| RII | 2,38,000 shares | 14,25,000 shares |
| Employee | ||
| Others | ||
| Total | 4,76,000 shares | 28,50,000 shares |
EP Biocomposites IPO subscribed 18.51x in total, whereas Jay Jalaram Technologies IPO subscribed 14.97x.
| EP Biocomposites IPO | Jay Jalaram Technologies IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 21.58x | 18.56x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 15.44x | 11.38x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 18.51x | 14.97x |
